|
People
The highly qualified, entrepreneurial spirited and motivated team at ESBATech encourage a creative and innovative culture, dedicated to developing ideas and finding solutions to significant therapeutic challenges in the treatment of ophthalmic diseases.
The Company has currently more than 70 employees. The majority hold an MD, Ph.D. or a Master of Science degree in the fields of Molecular Biology, Biochemistry, Immunology or Medicine.
| Senior Management |
|
|
| Dominik Escher, Ph.D. | Managing Director and VP R&D | >> CV
|
| Jacques Gaudreault, Ph.D. | Head Research and Preclinical Development |
| Lea Ryter Ciampi | Head Human Resources |
| Anne Schmidt, Ph.D. | Head Project Management | >> CV
|
| Peter Steiner, Ph.D. | Head Production & Processes | >> CV
|
| Georges Weissgerber, M.D. | Head Clinical Research and Development / Med. Director |
| Key Personnel |
|
|
| Jürgen E. Bader, Ph.D. |
Head Pharmaceutical Production |
|
| Ulrich Bauer | Head Fermentation and Standard Productions |
|
| Rouven Bingel-Erlenmeyer, Ph.D. | Head Downstream Processing & Analytics |
|
| Leo Borras | Head Protein Engineering |
|
| Esther Furrer, Ph.D. | Project Head |
|
| John Grimshaw, Ph.D. | Head Structural Biophysics and Formulation |
|
| Colin Hughson, MD | Drug Safety Officer |
|
| Valérie Hulmann, Ph.D. | Head Screening Technology |
|
| Markus Jauslin | Head of Accounting |
|
| Sushanta Mallick, Ph.D. | Head Clinical Trial Management |
|
| Patrik Maurer, Ph.D. | Project Head |
|
| Hermann Schulze, Ph.D. | Head Regulatory Affairs and Quality Assurance |
|
| Konstantin von Schulthess | Manager Finance |
|
|
